Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis | MicrobiomeTrials← Back to trialsNCT07230288
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-01-23Est. Completion: 2029-09
Enrollment target: 165 participants Locations- The University of Alabama at Birmingham /ID# 277613, Birmingham, Alabama, United States
- Sec Clinical Research - East - Dothan - Graceland /ID# 278328, Dothan, Alabama, United States
- Clinical Research Specialists - Kissimmee /ID# 279184, Kissimmee, Florida, United States
- Christie Clinic on University /ID# 277871, Champaign, Illinois, United States
- University of Michigan Health System - Ann Arbor /ID# 279994, Ann Arbor, Michigan, United States
- Henry Ford Hospital /ID# 277843, Detroit, Michigan, United States
- Hannibal Regional Hospital /ID# 277984, Hannibal, Missouri, United States
- Jefferson Health Honickman Center /ID# 279127, Philadelphia, Pennsylvania, United States
- Inova Fairfax Hospital /ID# 278469, Falls Church, Virginia, United States
- Virginia Commonwealth University Medical Center /ID# 277992, Richmond, Virginia, United States
- Lung Research Queensland /ID# 278838, Nundah, Queensland, Australia
- Eastern Health /ID# 278245, Box Hill, Victoria, Australia
- University Multiprofile Hospital for Active Treatment Dr. Georgi Stranski /ID# 277845, Pleven, Bulgaria
- University Multiprofile Hospital For Active Treatment Sveti Georgi - Plovdiv /ID# 279367, Plovdiv, Bulgaria
Other microbiome trials you might be interested in
Interstitial Lung DiseaseChronic Obstructive Pulmonary DiseaseHypoxemia
Fibrotic forms of interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) are chronic lung dise…
Buffalo, United StatesCompleted Oct 2027
Idiopathic Pulmonary Fibrosis
This is a randomized, placebo-controlled trial of metformin in 400 participants with idiopathic pulmonary fibrosis (IPF)…
Tucson, United StatesEst. completion Mar 15, 2029
Acibadem City Clinic Tokuda University Hospital EAD /ID# 277846, Sofia, BulgariaDiagnostic Consultative Center Convex /ID# 277848, Sofia, BulgariaDiagnostic Consultative Center Convex /ID# 277849, Sofia, BulgariaCentre d'Investigation Clinique Mauricie /ID# 277949, Trois-Rivières, Quebec, CanadaHopital Arnaud de Villeneuve /ID# 278322, Montpellier, Herault, FranceCentre Hospitalier Universitaire de Rennes - Hopital Pontchaillou /ID# 278333, Rennes, Ille-et-Vilaine, FranceHopital Avicenne /ID# 279212, Bobigny, Île-de-France Region, FranceKlinikum Konstanz /ID# 278139, Konstanz, Baden-Wurttemberg, GermanyCaritas-Krankenhaus St. Maria gGmbH /ID# 278138, Donaustauf, Bavaria, GermanyUniversity General Hospital of Patras /ID# 277726, Pátrai, Achaia, GreeceGeneral Hospital of Chest Diseases of Athens SOTIRIA /ID# 277724, Athens, Attica, GreeceUniversity General Hospital of Heraklion /ID# 277717, Heraklion, Crete, GreeceUniversity Hospital of Ioannina /ID# 277719, Ioannina, GreeceGeneral Hospital of Thessaloniki George Papanikolaou /ID# 277819, Thessaloniki, GreeceNHO Kinki Chuo Chest Medical Center /ID# 280225, Sakai-shi, Osaka, JapanVitamed Galaj i Cichomski Sp.j. /ID# 278145, Bydgoszcz, Kuyavian-Pomeranian Voivodeship, PolandUnidade Local de Saude de Loures-Odivelas-Hospital Beatriz Angelo /ID# 278357, Loures, Lisbon District, PortugalUnidade Local de Saude de Matosinhos EPE /ID# 277980, Senhora da Hora, Porto District, PortugalUnidade Local de Saude do Algarve, EPE /ID# 278388, Faro, PortugalUniversity Clinical Center Serbia /ID# 278496, Belgrade, Beograd, SerbiaInstitute For Pulmonary Diseases Of Vojvodina /ID# 278499, Kamenitz, Sremski Okrug, SerbiaDr Hannes J van Rensburg inc /ID# 278278, Cape Town, Western Cape, South AfricaDr JM Engelbrecht Trial Site /ID# 278287, Somerset West, Western Cape, South AfricaInje University Haeundae Paik Hospital /ID# 278000, Busan, Busan Gwang Yeogsi, South KoreaThe Catholic University Of Korea, Bucheon St. Mary'S Hospital /ID# 278068, Bucheon-si, Gyeonggido, South KoreaSeoul National University Bundang Hospital /ID# 278059, Seongnam-si, Gyeonggido, South KoreaYonsei University Health System Severance Hospital /ID# 278166, Seoul, Seoul Teugbyeolsi, South KoreaHospital Clinico Universitario de Valencia /ID# 277921, Valencia, SpainHospital Universitari i Politecnic La Fe /ID# 278478, Valencia, SpainKaohsiung Medical University Chung-Ho Memorial Hospital /ID# 278029, Kaohsiung City, TaiwanKaohsiung Chang Gung Memorial Hospital /ID# 278043, Kaohsiung City, TaiwanChina Medical University Hospital /ID# 278039, Taichung, TaiwanNational Taiwan University Hospital /ID# 278041, Taipei, TaiwanTaipei Veterans General Hospital /ID# 278038, Taipei, TaiwanLinkou Chang Gung Memorial Hospital /ID# 278042, Taoyuan City, TaiwanGulhane Egitim ve Arastirma Hastanesi /ID# 278944, Ankara, Antalya, Turkey (Türkiye)Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 278943, Istanbul, Turkey (Türkiye)Royal Papworth Hospital NHS Foundation Trust /ID# 278055, Cambridge, Cambridgeshire, United KingdomEdinburgh Royal Infirmary - NHS Lothian /ID# 278631, Edinburgh, Edinburgh, City of, United KingdomUCLH NHS FT - University College Hospital /ID# 279198, London, Greater London, United KingdomRoyal Brompton Hospital /ID# 278007, London, Greater London, United KingdomUniversity Hospital Southampton /ID# 278223, Southampton, Hampshire, United KingdomNorfolk and Norwich University Hospital /ID# 278224, Norwich, Norfolk, United KingdomPhase 2
Recruiting
Idiopathic Pulmonary Fibrosis (IPF)
Rationale: LTI-03 is an experimental medication breathed into the lungs using an inhaler. It is being studied for the tr…
Birmingham, United StatesEst. completion Sep 30, 2027